Skip to content

The Effect of a Modified Bone Window Repositioning Technique on Bone Augmentation Outcomes in Simultaneous Implant Placement with Maxillary Sinus Floor Elevation: A Retrospective Radiographic Study

The Effect of a Modified Bone Window Repositioning Technique on Bone Augmentation Outcomes in Simultaneous Implant Placement with Maxillary Sinus Floor Elevation: A Retrospective Radiographic Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124762
Enrollment
Unknown
Registered
2026-05-17
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dentition defect

Interventions

A group(modified bone window repositioning technique):None
B group(traditional bone window repositioning technique):None

Sponsors

Stomatology Hospital,Zhejiang University School Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. All patients who underwent 27 implants of concurrent maxillary sinus lift with the Affiliated Stomatological Hospital of Zhejiang University School of Medicine from September 2024 to September 2025; 2. Age>=18 years old; 3. Missing one or more maxillary posterior teeth with healing time of more than 3 months; 4. Have complete basic information and detailed surgical records; 5. Complete CBCT imaging data before surgery (T0), immediately after surgery (T1) and 6 months after surgery (T2); 6. Alveolar bone height (RBH) <=6 mm shown by CBCT at the missing tooth site in T0 stage; 7. No systemic disease before surgery, and no treatment for apical or periodontal disease.

Exclusion criteria

Exclusion criteria: 1.Untreated maxillary pathologies that had not received standard treatment. 2.Presence of conditions that may affect normal bone metabolism, such as systemic diseases known to severely impact bone metabolism (e.g., uncontrolled diabetes mellitus, osteoporosis), a history of head and neck radiotherapy, or current/recent use (within the past 6 months) of medications affecting bone metabolism (e.g., bisphosphonates, corticosteroids). 3.Pregnancy or lactation. 4.History of head and neck cancer radiotherapy within the past 5 years. 5.Presence of acute or chronic inflammation in the maxillary sinus. 6.Requirement for additional vertical or horizontal bone augmentation using intrasinus graft materials beyond the maxillary sinus floor elevation via lateral window approach. 7.Heavy smokers (daily consumption exceeding 20 cigarettes at the time of surgery).

Design outcomes

Primary

MeasureTime frame
buccal augmentation volume;endo-sinus bone gain;Buccal bone height;augmentation volume;apical bone height;Palatal bone height;bone window in-situ rate;palatal augmentation volume;

Secondary

MeasureTime frame
LDL/LWL ratio;implant early loss rate;sinus perforation rate;

Countries

China

Contacts

Public ContactGuoli Yang

Stomatology Hospital,Zhejiang University School Medicine

guo_li1977@zju.edu.cn+86 13600529781

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026